BioCentury
ARTICLE | Company News

Illumina rises after introducing new products, deals

January 11, 2017 12:00 AM UTC

Illumina Inc. (NASDAQ:ILMN) gained $23.50 (17%) to $165.04 on Tuesday after introducing new products and collaborations, including the launch of the NovaSeq series of high throughput sequencers. The company said the systems could "one day" enable $100 genome sequencing.

Illumina said the NovaSeq systems will have outputs of up to 20 billion reads in about two days, with increased flexibility over previous models at a lower cost per sample. Illumina expects to begin shipping the systems, NovaSeq5000 and NovaSeq6000, by mid-2017. The systems will cost $850,000 and $985,000, respectively...

BCIQ Company Profiles

IBM Corp.

Illumina Inc.